Plexium
PrivateLast Round
VC Round
Aug 25, 2025
Total Funding Raised
$165.1M
Company Overview
Plexium is a biotechnology company that develops targeted protein degradation therapeutics for the treatment of cancer and other serious diseases.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Drug Discovery
Business Model
B2B
Customer Profile
Services & Consulting
AI Layer
Application
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Plexium Comps
Public and private peers based on sector, stage, and business model.
| Company | Status | Est. Valuation | Rev Multiple |
|---|---|---|---|
| OpenAI | Private | $86.0B | ~40x |
| Cohere | Private | $5.0B | -- |
| Competitor 1 | Public | $XX.XB | XXx |
| Competitor 2 | Public | $XX.XB | XXx |
Plexium Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| VC Round | Aug 25, 2025 | ||||
| VC Round | Aug 25, 2024 | ||||
| Series B | Feb 23, 2022 | ||||
| Series A Extension | Jan 21, 2021 | ||||
| Series A | Oct 17, 2019 | ||||
Seed | Feb 1, 2018 |
Plexium Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| The Column Group | Series B, Series A, Series A Extension |
| Surveyor Capital | Series B |
| SoftBank Investment Advisers | Series B |
| RA Capital Management | Series B |
| TCG Crossover | Series B |
| A. M. Pappas & Associates | Series B |
| DCVC Bio | Series A Extension, Series B, Series A |
Market signals
Structured signals derived from secondary market and firmographic data.
- Apr 28, 2025
Developing selective monovalent degrader programs targeting SMARCA2, IKZF2, and CDK2.
- Apr 28, 2025
Multiple presentations scheduled for AACR 2025 conference.
Plexium Filings
SEC and related filings with document metadata.
| Typed | Date | Amount Offered | Amount Sold | Filling | Pages | Download |
|---|---|---|---|---|---|---|
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Frequently Asked Questions
Common questions about Plexium's valuation, stock price, and market status.